To date, clinical trials of neuroprotective agents in preterm infants have been limited, but new data suggest that erythropoietin might have important neuroprotective effects in these vulnerable ...
Randomized trials with recombinant human erythropoietin ... effects on clinical outcome. Preliminary clinical trials in anemic patients with chronic HF demonstrate that erythropoietin therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback